Model Behavior: How Medtech Companies Can Make the SaaS Transition

Posted by Dan Frey on March 7, 2019

In my previous blog post, I discussed the challenges that medtech companies face when they transition from a capital equipment business model to one in which software features prominently. Once the company has identified the right team, organizational structure and operating model that allows software solutions to innovate and develop properly, and once it has understood the buying process sufficiently, the company then faces the toughest challenge: pricing and customer transitions.


>
Read More

Making Software a Core Part of Your Business Model

Posted by Dan Frey on February 22, 2019

In recent years, medtech companies have started to diversify outside of their core device offerings in an effort to meet the evolving needs of their customers and to open up new revenue streams. 


>
Read More

Generating Value Through Digital and Connected Health Analytics

Posted by Vishal Srivastava on February 13, 2019

"Digitization" has been disrupting several parts of the economy, including the medical devices industry. Beyond the initial hype, we see several programs beginning to show real results and that look promising for improving quality and decreasing healthcare costs. The industry is beginning to look at digital health solutions to drive differentiation as it moves toward focusing on healthcare value and outcomes.


>
Read More

Five Analytics Trends on the Horizon in Medtech

Posted by Bhargav Mantha on January 31, 2019

Maria Kliatchko co-wrote this blog post with Bhargav Mantha.

With the holidays well behind us, it’s time to take stock of 2018 and discuss what’s ahead for 2019 and beyond. In the past few years, advanced analytics has become much more accessible for many non-tech companies, driven by cheaper storage and improved processing power. Healthcare and the life sciences industries, in particular, are now seeing a lot of interest in the growing volumes of healthcare data, along with increased demand in outcomes-based product design and commercialization from regulators, customers and communities.


>
Read More

Into 2019: Risk, Uncertainty and a Return to Product Focus

Posted by Brian Chapman on January 23, 2019

Looking ahead to what the medtech industry can expect in 2019, I see a continuation of some of the greatest accomplishments of 2018, such as ongoing collaboration with regulatory bodies and real-world evidence driving more reimbursement discussions, as well as the brave new world of digital health continuing to buoy how our industry can help patients.


>
Read More